Atika Capital Management LLC Veracyte, Inc. Transaction History

Atika Capital Management LLC

  • $874 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$20.78 - $29.99 $3.01 Million - $4.35 Million
-145,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$23.87 - $30.93 $190,960 - $247,440
8,000 Added 5.84%
145,000 $3.48 Million
Q2 2019

Aug 12, 2019
BUY
$22.1 - $28.56 $3.03 Million - $3.91 Million
137,000 New
137,000 $3.91 Million

Others Institutions Holding VCYT

# of Institutions
307
Shares Held
81.7M
Call Options Held
134K
Put Options Held
13.3K
View Full List

About VERACYTE, INC.

VCYT Quotes by TradingView
  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email